Deferred Tax Assets, Valuation Allowance in CNY of Burning Rock Biotech Ltd from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2019 to Q4 2024.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was ¥596M, a 11.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance (CNY)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 596M +60.5M +11.3% Dec 31, 2024 20-F 2025-04-29
Q4 2023 535M +98.5M +22.6% Dec 31, 2023 20-F 2025-04-29
Q4 2022 437M +173M +65.3% Dec 31, 2022 20-F 2024-04-29
Q4 2021 264M +93.9M +55.1% Dec 31, 2021 20-F 2023-04-20
Q4 2020 170M +52.2M +44.2% Dec 31, 2020 20-F 2022-04-29
Q4 2019 118M Dec 31, 2019 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.